Although increased MDM4 levels have been associated with better prognosis and cisplatin chemosensitivity in ovarian cancer [19,26], subcellular localization of MDM4 has not been investigated in tissue specimens. This evidence concerns the gene MDM4 and ovarian carcinoma.